Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Mar 17;10(3):e0119268.
doi: 10.1371/journal.pone.0119268. eCollection 2015.

Analysis of resistance to antimicrobials and presence of virulence/stress response genes in Campylobacter isolates from patients with severe diarrhoea

Affiliations

Analysis of resistance to antimicrobials and presence of virulence/stress response genes in Campylobacter isolates from patients with severe diarrhoea

Haitham Ghunaim et al. PLoS One. .

Abstract

Campylobacter infections are a major cause of diarrhoea world-wide and two of the antimicrobials used for their control (erythromycin and ciprofloxacin) have been losing efficacy in recent years. In a sample of 174 genotyped isolates from the stools of patients with severe diarrhoea in Qatar, collected between 2005 and 2012, 63.2% showed resistance to ciprofloxacin, 8.6% to erythromycin, 0.57% to chloramphenicol and all were sensitive to gentamycin. While 33.9% of isolates were sensitive to all four antimicrobials, 59.8% were resistant to at least one, 6.3% were resistant to two and none showed resistance to three antimicrobials. There was no host sex- or age-dependence among isolates resistant to ciprofloxacin and erythromycin and no significant variation was found with the region of origin of the patients. All isolates were screened for the presence of 3 virulence factors (ciaB, cadF and cdtB) and two stress-response factors (htrB and clpP), all of which were present in more than 50% of the isolates. Host sex-, age- and region of origin-dependent variations in prevalence were found for some of these factors. Data analysis for the combination of virulence factors and their effect on antimicrobial resistance indicated that the prevalence of resistance to both erythromycin and ciprofloxacin was higher in isolates harbouring ciaB but not clpP. Prevalence of resistance to ciprofloxacin was similar in clpP positive and negative isolates also possessing htrB, while for htrB-negative isolates prevalence was higher in the absence of clpP. These results are discussed and their implications are highlighted.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Prevalence of enteric bacteria in the stools of outpatients reporting to the MHC with severe diarrhoea in the period 2005–2013.
The sample sizes for 2005–2013 were 2220, 1916, 2460, 2394, 2528, 2726, 3347, 4373 and 4176, respectively.
Fig 2
Fig 2. Prevalence of the virulence factor ciaB (A) and htrB (B) among male and female subjects in each of the age classes (A) and from each of the five regions of origin used for analysis (B).
The sample sizes in A were as follows: for the 104 male subjects, 22, 24, 21, 26 and 11, and for the 70 female subjects 12, 20, 10, 17 and 11 for age classes 1–5 respectively in both cases. For the age span and average age of each age class see Materials and Methods. The sample sizes in B were as follows: for the 104 male subjects, 46, 18, 26, 11 and 3, and for the 70 female subjects 26, 15, 16, 10 and 3 for the five regions of origin (Qatar, Arabian Peninsula, Asia, Africa and elsewhere) respectively in both cases. For further details of countries of origin in each region see Materials and Methods.
Fig 3
Fig 3. Prevalence of resistance to ciprofloxacin (A and B) and erythromycin (C) in Campylobacter isolates which were positive or negative for the clpP virulence factor, in the presence/absence of CiaB (A and C) and htrB (B).
Sample sizes are given on the columns in A and B, and for C the sample sizes were the same as in A.

References

    1. Moore JE, Corcoran D, Dooley JS, Fanning S, Lucey B, Matsuda DA, et al. Campylobacter. Vet Res. 2005; 36: 351–382. - PubMed
    1. Cover TL, Perez-Perez GI, Blaser MJ. Evaluation of cytotoxic activity in fecal filtrates from patients with Campylobacter jejuni or Campylobacter coli enteritis. FEMS Microbiol Lett. 1990; 58: 301–304. - PubMed
    1. Szymanski CM, Gaynor EC. How a sugary bug gets through the day: recent developments in understanding fundamental processes impacting Campylobacter jejuni pathogenesis. Gut Microbes 2012; 3: 135–144. 10.4161/gmic.19488 - DOI - PMC - PubMed
    1. Young KT, Davis LM, Dirita VJ. Campylobacter jejuni: molecular biology and pathogenesis. Nat Rev Microbiol. 2007; 5: 665–679. - PubMed
    1. Nachamkin I, Ung H, Li M. Increasing fluoroquinolone resistance in Campylobacter jejuni, Pennsylvania, USA,1982–2001. Emerg Infect Dis. 2002; 8: 1501–1503. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources